|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone显示文摘 | Johnson NA Slack GW Savage KJ | 2012 | J Clin Oncol2012，30，28： | 1 |
| 2 | Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone 显示文摘 | Johnson NA Slack GW Savage K J | 2012 | J Clin Oncol2012，30，28： | 1 |
| 3 | Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with Rituximab plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone 显示文摘 | Johnson NA Slack GW Savage K J | 2012 | J Clin Oncol2012，30，28： | 1 |
| 4 | MYC and aggressive B-cell lymphomas显示文摘 | Slack GW Gascoyne RD | 2011 | Adv Anat Pathol2011，18，3： | 1 |
| 5 | Concurrent expression of MYC and Bcl2 in diffuse large B-cell lymphoma treated with rit- uximab plus cyelophosphamide, doxorubiein, vineristine, and prednisone 显示文摘 | Johnson NA Slack GW Savage IQ | 2012 | J Clin Oneol2012，30，28： | 1 |
| 6 | Concurrentexpression of MYC and BCL2 in diffuse large B-cell lymphomatreated with rituximab plus cyclophosphamide, doxorubicin,vincristine, and prednisone显示文摘 | Johnson NA Slack GW Savage KJ | 2012 | J Clin Oncol?2012，30，： | 1 |
| 7 | CD30 expression in de novo diffuse large B-cell lymphoma: a population-based study from British Columbia显示文摘 | Slack GW Steidl C Sehn LH | 2014 | Br J Haematol2014，167，5： | 1 |
| 8 | MYC and aggressive B-cell lymphomas显示文摘 | Slack GW Gascoyne RD | 2011 | Adv Anat Pathol2011，18，3： | 1 |
| 9 | Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone显示文摘 | Johnson NA Slack GW Savage KJ | 2012 | J Clin Oncol2012，30，28： | 1 |
| 10 | Concurrent expression of MYC and BCL2 in diffuse large B- cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone显示文摘 | Johnson NA Slack GW Savage KJ | 2012 | J Clin Oncol2012，30，28： | 1 |
| 11 | Concurrent ex- pression of MYC and Bcl-2 in diffuse large B-cell lym- phoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone 显示文摘 | Johnson NA Slack GW Savage KJ | 2012 | J Clin On- col2012，30，28： | 1 |
| 12 | Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxombicin, vincristine, and prednisone显示文摘 | Johnson NA Slack GW Savage KJ | 2012 | J CIin Oncol2012，30，28： | 1 |
| 13 | Concurrent expression of MYC and BCL2 in diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisane显示文摘 | Johnson NA Slack GW Savage KJ | 2012 | J Clin Oncol2012，30，： | 1 |
| 14 | MYC and aggressive B-cell lymphomas显示文摘 | Slack GW Gascoyne RD | 2011 | Adv Anat Pathol2011，18，3： | 1 |
| 15 | Concurrent expression ofMYC and BCL-2 in diffuse large B-cell lymphoma treated withrituximab plus cyclophosphamide, doxorubicin, vincristine, andprednisone显示文摘 | Johnson NA Slack GW Savage KJ | 2012 | J Clin Onocl2012，30，28： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员